Teva Pharmaceutical Industries LimitedTEVA

Is TEVA cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$37.09+0.74 (+2.04%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$44B
Large-cap
-10%
2016 — today
10-Year Price
-30%
2016 — today
52-Week Range
$18.34$38.10
Current $37.09· 95%

Teva Pharmaceutical Industries develops, manufactures, and markets generic, specialty, and biopharmaceutical products across North America, Europe, and international markets. Its portfolio spans sterile items, hormones, and cytotoxic agents in various delivery forms, alongside active pharmaceutical ingredients (APIs). Key therapeutic areas include CNS disorders (Copaxone, AJOVY, AUSTEDO), respiratory ailments (ProAir, QVAR, CINQAIR), and oncology (Bendeka, Treanda). Founded in 1901, the Tel Aviv-based firm also collaborates on long-acting injectables.

Similar companies

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
61.8
Near historic high
Near historic highs — last 10 years
Sector median 24.4above sector
P/B ratio
5.6
Near historic high
Near historic highs — last 10 years
Sector median 2.5above sector
EV / EBITDA
22.0
Historically pricey
Historically pricey — last 10 years
Sector median 15.2above sector
FCF Yield
3.1%
Below average
Below the 10-year average
Sector median -9.6%above sector
Free · No credit card needed

Get alerted when TEVA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.